ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
Titel:
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
Auteur:
Wrangle, John M Velcheti, Vamsidhar Patel, Manish R Garrett-Mayer, Elizabeth Hill, Elizabeth G Ravenel, James G Miller, Jeffrey S Farhad, Mohammad Anderton, Kate Lindsey, Kathryn Taffaro-Neskey, Michele Sherman, Carol Suriano, Samantha Swiderska-Syn, Marzena Sion, Amy Harris, Joni Edwards, Andie R Rytlewski, Julie A Sanders, Catherine M Yusko, Erik C Robinson, Mark D Krieg, Carsten Redmond, William L Egan, Jack O Rhode, Peter R Jeng, Emily K Rock, Amy D Wong, Hing C Rubinstein, Mark P